TVMR With the Innovalve System Trial - Pilot in Georgia

NCT05682066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2025-04-23

No results posted yet for this study

Summary

Study to evaluate the safety and performance of the Innovalve mitral valve replacement system

Conditions

  • Mitral Valve Regurgitation (Degenerative or Functional)

Interventions

DEVICE

Innovalve MR system

Innovalve MR system

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • Georgia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05682066 on ClinicalTrials.gov